United StatesPerampanel CIII Tablets, 6 mg, Rx only, 30-count bottles (NDC 51672-4206-6) manufactured by Taro Pharmaceutical Industries Ltd. and distributed by Sun Pharmaceutical Industries, Inc., lot AE01763, exp. 9/30/2027 (3,456 bottles sold nationwide in the U.S.). The recall was issued because of a label mix-up in which a 10 mg Perampanel CIII tablet was found in a bottle labeled Perampanel 6 mg tablets.
What's being recalled
Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, Mfd.by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 51672-4206-6
Recalling firm: Sun Pharmaceutical Industries Inc, Princeton, NJ, United States.
How to identify it
Lot AE01763, Expires 9/30/2027.
The hazard
Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide in the USA
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)